Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Option-To-Acquire In Medical Device Deals Rarely Gets Exercised

This article was originally published in Start Up

Executive Summary

For a device start-up, an option to acquire presents a clear path to liquidity, but there are drawbacks. An analysis of deals in Elsevier’s Strategic Transactions suggests the importance of such options to the overall merger and acquisition ecosystem might be overblown.

Advertisement

Related Content

Neuromodulation Start-Ups: Abundant Funding, Slow Exits
Device/Diagnostics Quarterly Deal Statistics, Q4 2013
Hospitals, Insurers Enjoy Growing Influence As VCs
Device Start-Ups Reap More Corporate Venture
Device/Diagnostics Quarterly Deal Statistics, Q3 2012
Corporate Venture Eyes The Early Stage
Cameron Health: Is This The Cure For An Ailing ICD Market?

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

MT037762

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel